Kalin Katherine Bach 4
4 · SELLAS Life Sciences Group, Inc. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Kalin Katherine Bach
Director
Transactions
- Award
Common Stock
2026-01-07+50,000→ 154,400 total
Footnotes (1)
- [F1]The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.